Screening and Detection of Congenital Hypothyroidism in Newborns

Area of Science:

• Pediatrics
• Endocrinology
• Neonatal Health

Background:

• Congenital hypothyroidism (CH) is a leading cause of preventable intellectual disability in children.
• Infants with CH are typically asymptomatic at birth, making early identification challenging.
• Untreated CH can lead to severe and irreversible cognitive impairment.

Purpose of the Study:

• To emphasize the critical importance of early detection of congenital hypothyroidism.
• To highlight the role of standardized newborn screening in mitigating cognitive deficits.
• To underscore the impact of timely intervention on infant neurodevelopment.

Main Methods:

• Review of existing literature on congenital hypothyroidism and newborn screening.
• Analysis of the consequences of unrecognized CH on cognitive outcomes.
• Evaluation of the effectiveness of standardized screening protocols.

Main Results:

• Unrecognized CH is the primary preventable cause of cognitive delay.
• Newborn screening programs are effective in identifying CH cases early.
• Early diagnosis and treatment significantly improve cognitive development outcomes.

Conclusions:

• Standardized newborn screening for CH is essential for preventing intellectual disability.
• Prompt identification and management of CH positively impact long-term cognitive function.
• Universal screening ensures timely intervention, safeguarding children's developmental potential.